Basit öğe kaydını göster

dc.contributor.authorBalci, Huriye
dc.contributor.authorErer, Burak
dc.contributor.authorSut, Necdet
dc.contributor.authorSenturk, Hakan
dc.contributor.authorHacibekiroglu, Munire
dc.contributor.authorOzbay, Gulsen
dc.contributor.authorImeryuz, Nese
dc.contributor.authorCanbakan, Billur
dc.contributor.authorTahan, Veysel
dc.contributor.authorHatermi, Ibrahim
dc.date.accessioned2021-03-03T12:21:36Z
dc.date.available2021-03-03T12:21:36Z
dc.date.issued2008
dc.identifier.citationCanbakan B., Tahan V., Balci H., Hatermi I., Erer B., Ozbay G., Sut N., Hacibekiroglu M., Imeryuz N., Senturk H., "Leptin in nonalcoholic fatty liver disease", ANNALS OF HEPATOLOGY, cilt.7, sa.3, ss.249-254, 2008
dc.identifier.issn1665-2681
dc.identifier.othervv_1032021
dc.identifier.otherav_2d896831-4398-47c1-8593-afd90bd942d8
dc.identifier.urihttp://hdl.handle.net/20.500.12627/35213
dc.identifier.urihttps://doi.org/10.1016/s1665-2681(19)31856-3
dc.description.abstractBackground: Non-alcoholic fatty liver disease (NAFLD) is a prevalent condition associated with obesity and insulin resistance (IR). Leptin plays a key role in the control of energy balance, and insulin sensitivity. In this study, we aimed to examine whether serum leptin levels correlate with insulin resistance, oxidative stress parameters and the severity of histological changes in NAFLD. Methods: Fifty-two patients (M/F: 28/24) with no alcohol intake and biopsy-proven diagnosis of NAFLD were studied. Serum leptin levels were measured by radioimmunoassay. HOMA (homeostasis model assessment) IR index was calculated. Comparisons between the patients with NAFLD and non-alcoholic steatohepatitis (NASH) were performed using the Student's t test. N-fultivariate regression analysis and the area under the receiver operating characteristic (ROC) curve were used to identify the independent predictors for NASH. Results: We found no association between serum leptin, fasting insulin levels, and oxidative stress parameters. ROC curve and multiple regression analysis revealed no association between the severity of histological changes and serum leptin levels. During six months followed-up period only NASH group with elevated leptin levels had significant reductions of ALT and AST values (p = 0.03, and 0.005, respectively). Conclusion: Our findings show a preventive effect of leptin against progressive liver injury in NAFLD.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.titleLeptin in nonalcoholic fatty liver disease
dc.typeMakale
dc.relation.journalANNALS OF HEPATOLOGY
dc.contributor.department, ,
dc.identifier.volume7
dc.identifier.issue3
dc.identifier.startpage249
dc.identifier.endpage254
dc.contributor.firstauthorID22653


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster